Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses
Open accessThe DOI matches its Crossref record; the references it cites are not checked yet.
Abstract
Background: The purpose of this review is to evaluate the data on the use of antipsychotics in individuals with dementia from meta-analyses. Methods: We performed a literature search of PubMed, MEDLINE, EMBASE, PsycINFO and Cochrane collaboration databases through 30 November, 2015 using the following keywords: ‘antipsychotics’, ‘dementia’ and ‘meta-analysis’. The search was not restricted by the age of the patients or the language of the study. However, in the final analysis we only included studies involving patients that were published in English language journals or had official English translations. In addition, we reviewed the bibliographic databases of published articles for additional studies. Results: This systematic review of the literature identified a total of 16 meta-analyses that evaluated the use of antipsychotics in individuals with dementia. Overall, 12 meta-analyses evaluated the efficacy of antipsychotics among individuals with dementia. Of these, eight also assessed adverse effects. A further two studies evaluated the adverse effects of antipsychotics (i.e. death). A total of two meta-analyses evaluated the discontinuation of antipsychotics in individuals with dementia. Overall, three meta-analyses were conducted in individuals with Alzheimer’s disease (AD) whereas one focused on individuals with Lewy Body Dementia (LBD). The rest of the 12 meta-analyses included individuals with dementia. Conclusions: Antipsychotics have demonstrated modest efficacy in treating psychosis, aggression and agitation in individuals with dementia. Their use in individuals with dementia is often limited by their adverse effect profile. The use of antipsychotics should be reserved for severe symptoms that have failed to respond adequately to nonpharmacological management strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, communication around new or modified use of antipsychotic medications during hospitalization may provide subsequent caregivers with critical knowledge on the therapeutic benefits, or lack thereof, for the patient with dementia which can inform later care management strategies.30, 45”
From Discharge Communication of Dementia-Related Neuropsychiatric Symptoms and Care Management Strategies during Hospital to Skilled Nursing Facility Transitions (2021) · cites this paper as [45]
Citations
The citation lists are queued
They are fetched later and appear here then.
References 51 · Cited by 267
Research works printed but not linked: 5
- Ballard C., 2006, Cochrane Database Syst Rev, 1, CD003476
- Cheung G., 2011, NZ Med J, 124, 39
- Declercq T., 2013, Cochrane Database Syst Rev, 3, CD007726
- Kirchner V., 2001, Cochrane Database Syst Rev, 3, CD000464
- Seitz D., 2011, Cochrane Database Syst Rev, 2, CD008191
Metadata
- Authors
- Tampi, R. R., Tampi, D. J., Balachandran, S., & Srinivasan, S.
- Affiliations
- MetroHealth (US)
- Saint Francis Hospital & Medical Center (US)
- University of South Carolina (US)
- Corresponding author
- Tampi, Rajesh R.
- Venue
- Therapeutic Advances in Chronic Disease
- Publisher
- SAGE Publications
- Published
- 2016-07-31
- Volume
- 7
- Issue
- 5
- Pages
- 229-245
- ISSN
- 2040-6223 (ISSN-L)
- 2040-6231
- PMC
- PMC4994396
- OpenAlex
- W2468352757
- Cited by
- 267
- References
- 51
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 26 · 2023: 37 · 2022: 32 · 2021: 45 · 2020: 29 · 2019: 25 · 2018: 13 · 2017: 4 · 2016: 1
- FWCI
- 2.05
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Therapeutic Advances in Chronic Disease (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- antipsychotic drugs, dementia, Alzheimer's disease, dementia with Lewy bodies, psychosis, aggression, agitation, adverse effects, drug efficacy, non-pharmacological treatment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. https://app.cochat.ai/papers/10.1177/2040622316658463
- The paper
- Tampi, R. R., Tampi, D. J., Balachandran, S., & Srinivasan, S. (2016). Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Therapeutic Advances in Chronic Disease. https://doi.org/10.1177/2040622316658463
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.